13-85794096-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_032229.3(SLITRK6):c.2413T>C(p.Tyr805His) variant causes a missense change. The variant allele was found at a frequency of 0.000157 in 1,613,064 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.00022 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00015 ( 0 hom. )
Consequence
SLITRK6
NM_032229.3 missense
NM_032229.3 missense
Scores
4
9
6
Clinical Significance
Conservation
PhyloP100: 7.14
Genes affected
SLITRK6 (HGNC:23503): (SLIT and NTRK like family member 6) This gene encodes a member of the SLITRK protein family. Members of this family are integral membrane proteins that are characterized by two N-terminal leucine-rich repeat (LRR) domains and a C-terminal region that shares homology with trk neurotrophin receptors. This protein functions as a regulator of neurite outgrowth required for normal hearing and vision. Mutations in this gene are a cause of myopia and deafness. [provided by RefSeq, Dec 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLITRK6 | NM_032229.3 | c.2413T>C | p.Tyr805His | missense_variant | 2/2 | ENST00000647374.2 | NP_115605.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLITRK6 | ENST00000647374.2 | c.2413T>C | p.Tyr805His | missense_variant | 2/2 | NM_032229.3 | ENSP00000495507.1 | |||
SLITRK6 | ENST00000643778.1 | c.2413T>C | p.Tyr805His | missense_variant | 3/3 | ENSP00000496428.1 |
Frequencies
GnomAD3 genomes AF: 0.000224 AC: 34AN: 151936Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
34
AN:
151936
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000230 AC: 57AN: 247932Hom.: 0 AF XY: 0.000201 AC XY: 27AN XY: 134462
GnomAD3 exomes
AF:
AC:
57
AN:
247932
Hom.:
AF XY:
AC XY:
27
AN XY:
134462
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000150 AC: 219AN: 1461010Hom.: 0 Cov.: 31 AF XY: 0.000154 AC XY: 112AN XY: 726824
GnomAD4 exome
AF:
AC:
219
AN:
1461010
Hom.:
Cov.:
31
AF XY:
AC XY:
112
AN XY:
726824
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000224 AC: 34AN: 152054Hom.: 0 Cov.: 32 AF XY: 0.000229 AC XY: 17AN XY: 74340
GnomAD4 genome
AF:
AC:
34
AN:
152054
Hom.:
Cov.:
32
AF XY:
AC XY:
17
AN XY:
74340
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
2
ALSPAC
AF:
AC:
0
ESP6500AA
AF:
AC:
2
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
22
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 21, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 1197937). This variant has not been reported in the literature in individuals affected with SLITRK6-related conditions. This variant is present in population databases (rs200882739, gnomAD 0.06%). This sequence change replaces tyrosine, which is neutral and polar, with histidine, which is basic and polar, at codon 805 of the SLITRK6 protein (p.Tyr805His). - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Apr 06, 2020 | In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 16, 2021 | The c.2413T>C (p.Y805H) alteration is located in exon 2 (coding exon 1) of the SLITRK6 gene. This alteration results from a T to C substitution at nucleotide position 2413, causing the tyrosine (Y) at amino acid position 805 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
SLITRK6-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 25, 2024 | The SLITRK6 c.2413T>C variant is predicted to result in the amino acid substitution p.Tyr805His. This variant has been reported in an individual with hearing loss (El Naofal et al 2023. PubMed ID: 36703223). This variant is reported in 0.060% of alleles in individuals of Latino descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
High myopia-sensorineural deafness syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Al Jalila Children’s Genomics Center, Al Jalila Childrens Speciality Hospital | Feb 11, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
.;.;D
M_CAP
Benign
D
MetaRNN
Uncertain
T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;M
PrimateAI
Pathogenic
D
PROVEAN
Benign
.;N;.
REVEL
Uncertain
Sift
Pathogenic
.;D;.
Sift4G
Uncertain
.;D;.
Polyphen
D;D;D
Vest4
0.81
MVP
0.93
MPC
0.33
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at